Rahi Jugnoo, Logan Stuart, Timms Christine, Russell-Eggitt Isabelle, Taylor David
Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, UK.
Lancet. 2002 Aug 24;360(9333):597-602. doi: 10.1016/s0140-6736(02)09782-9.
Screening for amblyopia in early childhood is done in many countries to ensure that affected children are detected and treated within the critical period, and achieve a level of vision in their amblyopic eye that would be useful should they lose vision in their non-amblyopic eye later in life. We aimed to investigate the risk, causes, and outcomes of visual impairment attributable to loss of vision in the non-amblyopic eye.
For 24 months from July, 1997, national surveillance was done to identify all individuals in the UK with unilateral amblyopia (acuity worse than 6/12) who had newly acquired vision loss in the non-amblyopic eye, resulting in acuity of worse than 6/12 or visual-field restriction precluding driving. Information about participants was obtained at presentation and 1 year later. Participants were categorised as having socially significant visual impairment, or visual impairment, severe visual impairment, or blindness, in accordance with WHO taxonomy.
Of 370 eligible individuals, at presentation 104 (28%) had socially significant visual impairment, 180 (49%) visual impairment, and 86 (23%) severe visual impairment or blindness. The minimum risk of permanent visual impairment by age 95 years was 32.9 (95% CI 29.1-36.9) per 100,000 total population. The projected lifetime risk of vision loss for an individual with amblyopia was at least 1.2% (95% CI 1.1-1.4). Only 36 (35%) of 102 people previously in paid employment were able to continue.
In the UK, where screening for amblyopia is under review, risk of serious vision loss affecting the non-amblyopic eye and its results are greater than that previously assumed. Thus, in addition to the benefits of improved vision in the amblyopic eye, treatment of amblyopia during childhood is a potentially valuable strategy to prevent incapacitating vision loss later in life.
许多国家都在幼儿期开展弱视筛查,以确保受影响的儿童在关键期内被发现并接受治疗,使其弱视眼达到一定视力水平,以便在日后非弱视眼失明时仍能具备有用的视力。我们旨在调查因非弱视眼失明导致视力损害的风险、原因及后果。
从1997年7月起的24个月内,开展了全国性监测,以识别英国所有单眼弱视(视力低于6/12)且非弱视眼新近失明、导致视力低于6/12或视野受限无法驾驶的个体。在个体就诊时及1年后获取其相关信息。根据世界卫生组织的分类标准,将参与者分为具有社会意义的视力损害、视力损害、严重视力损害或失明。
在370名符合条件的个体中,就诊时,104人(28%)有具有社会意义的视力损害,180人(49%)有视力损害,86人(23%)有严重视力损害或失明。每10万总人口中,到95岁时永久性视力损害的最低风险为32.9(95%可信区间29.1 - 36.9)。弱视个体预期的终生视力丧失风险至少为1.2%(95%可信区间1.1 - 1.4)。102名之前有带薪工作的人中,只有36人(35%)能够继续工作。
在英国,弱视筛查正在接受审查,非弱视眼发生严重视力丧失的风险及其后果比之前设想的更大。因此,除了改善弱视眼视力的益处外,儿童期治疗弱视是预防日后导致失能性视力丧失的一项潜在重要策略。